Share Talk LTD

Share Talk LTD

Download on the App Store

All Share Talk LTD episodes

  • David Minchin, Chief Executive Officer, Helium One Group Ltd (HE1.L) Interview
    Helium One last major official announcement was the commencement of its infill seismic campaign with mobilisation of survey and line-clearing crews to its Rukwa project (100%) in Tanzania.

    We spoke with David today and it looks like HE1 will have a lot of news flow to come in 2021.
    "It's an exciting time for the team at Helium One and for all our stakeholders, as this will be our largest on site mobilisation for several years. Data gathered from infill seismic will prove invaluable in refining drill targets and improving our knowledge of potential trap structures, leading to what we hope will be a 'game changing' drilling campaign in Q2 2021.

    https://www.share-talk.com/david-minchin-chief-executive-officer-helium-one-group-ltd-he1-l-interview/

    6 min
  • Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals (HEMO.L) Interview
    Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce its participation at the H.C. Wainwright Global Life Sciences Conference. The Company will be featured as a presenting company. The conference will be held on a virtual platform from March 9-10, 2021.

    As part of the Company's presentation, Dr. Vladislav Sandler, CEO of Hemogenyx Pharmaceuticals, will provide an overview of the Company's business and product candidates.

    If you are an institutional investor, and would like to listen to the Company's presentation, please click on the following link to register for the conference: www.hcwevents.com/globalconference.

    The conference will feature over 400 corporate presentations and panels both live and on-demand. Dr. Sandler's presentation is accessible using a webcast link.

    Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals, commented: "Our presentation at the H.C. Wainwright Global Life Sciences Investment Conference provides the Company with a great opportunity to inform the investment community about our achievements and increase the Company's visibility globally. It also allows us to further establish Hemogenyx Pharmaceuticals as a leader in the field of the development of medicines for treatment of blood and autoimmune diseases. "

    https://www.share-talk.com/dr-vladislav-sandler-ceo-co-founder-of-hemogenyx-pharmaceuticals-hemo-l-interview/

    14 min
  • Weekend Edition, Bulletin Board Heroes, Sunday 7th March 2021
    Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.

    Avacta Group (AVCT)
    Conduity Capital (CCAP)
    Eco Atlantic Oil & Gas (ECO)
    Echo Energy (ECHO)
    Ince Group (INCE)
    JKX Oil and Gas (JKX)
    Premier African Minerals (PREM)
    Photo-Me International (PHTM)
    Scancell Holdings (SCLP)
    Trinity Exploration & Production (TRIN)
    Toople (TOOP)
    TLOU Energy (TLOU)

    Zakmir.com is a purely journalistic website – Zak Mir is a member of the National Union of Journalists. There is no intention here of providing financial advice. It is recommended you seek an independent professional opinion before deciding whether or not to take any action with regard to anything written here.

    (The opinions expressed here are those of the author, a columnist for Share Talk.)

    https://www.share-talk.com/weekend-edition-bulletin-board-heroes-sunday-7th-march-2021/
    11 min
  • Share Talk Bulletin Board Heroes, Friday 5th March 2021
    Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.

    ARC Minerals (ARCM)
    Clear Leisure (CLP)
    Europa Oil & Gas (Hldgs) (EOG)
    Enquest 9ENQ)
    Genedrive (GDR)
    Hemogenyx Pharmaceuticals (HEMO)
    Infrastructure India (IIP)
    Origo Partners (OPP)
    Path Investments (PATH)
    Revolution Bars Group (RBG)
    Tullow Oil (TLW)
    Zoetic International (ZOE)

    Zakmir.com is a purely journalistic website – Zak Mir is a member of the National Union of Journalists. There is no intention here of providing financial advice. It is recommended you seek an independent professional opinion before deciding whether or not to take any action with regard to anything written here.

    (The opinions expressed here are those of the author, a columnist for Share Talk.)

    https://www.share-talk.com/share-talk-bulletin-board-heroes-friday-5th-march-2021/
    11 min
  • Eric Schrader of Ox Distribution talks about Zoetic International's (ZOE.L) retail roll-out.
    Ox Distribution is the global sales force behind CBD company Zoetic Interntnl PLC (ZOE) with the commencement of trading on the OTCQX in January 2021.

    The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Graduating to the OTCQX Market from the OTCQB Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among U.S. investors.
    Zoetic's ordinary shares will continue to trade on the London Stock Exchange under the symbol ZOE.

    Zoetic-branded CBD products are sold in both the UK and Europe.
    This is the Company’s premium brand and it seeks to distinguish itself from its competitors by producing high quality products with full transparency of ingredients (disclosed on the label and the Company’s own website). Zoetic sells CBD oils (tinctures) and softgels as well as cosmetics and beauty products. 

    https://www.share-talk.com/eric-schrader-of-ox-distribution-talks-about-zoetic-internationals-zoe-l-retail-roll-out/
    12 min
  • Vadim Alexandre, Healthcare Analyst, SP Angel talks diagnostic stocks.
    The premise of this interview is to see what the landscape looks like with testing -  diagnostic companies as we approach the vaccine salvation promised land, who will be the winners and losers?

    SP Angel is an independent partnership providing creative, capital markets solutions to growing companies.
    The Healthcare sector includes companies driving all facets of healthcare markets including biotechnology, pharmaceuticals, medical devices & technologies, and healthcare services.

    The SP Angel Healthcare Team represents clients from across the industry, including companies at the forefront of biotechnology, pharmaceuticals, medical devices, digital health and healthcare services. Our team has established a solid reputation in helping clients secure private and public funding at every stage of their journey, from preclinical work to commercialisation, and sale/acquisition.

    https://www.share-talk.com/vadim-alexandre-healthcare-analyst-sp-angel-talks-diagnostic-stocks/

    14 min
  • Antony Legge, Interim Executive Chairman, Remote Monitored Systems (RMS.L) Interview
    Finally, we got the opportunity to speak with Antony about today company update and ask a few questions we hope shareholders find informative. What is cleary stated, P2F’s company portfolio is broader than the current focuses on mask production. 

    Antony Legge, Executive Chairman of RMS, said; “We are very pleased to update the market with the positive developments achieved by the P2F team. Whilst a number of issues remain with the machine at BioCity, the purchase order with Volz coupled with the intentions by both parties to enter into a more formal outsourced manufacturing agreement means P2F can commence sales with confidence as we anticipate a continuing market need for P2F’s proprietary α-virion material, notwithstanding the progress of various national Covid-19 vaccination programmes.”

    https://www.share-talk.com/antony-legge-interim-executive-chairman-remote-monitored-systems-rms-l-interview/

    7 min
  • Tony Calamita, CEO of Love Hemp Group PLC (LIFE:OTCQB) Interview
    (Formerly World High Life PLC)

    Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF ), is pleased to announce that, further to the Company's announcement on 15 February 2021, the change of name from World High Life PLC to Love Hemp Group PLC has become effective.

    All share certificates that are presently in the hands of investors will be valid and do not need to be exchanged for new share certificates.

    Andrew Male, Chairman and Director of Love Hemp, says "The name change aligns the listed company with the operational entity and most importantly, the brand that everyone knows, Love Hemp."

    https://www.share-talk.com/tony-calamita-ceo-of-love-hemp-group-plc-lifeotcqb-interview/

    12 min
  • Share Talk Bulletin Board Heroes, Thursday 4th March 2021
    Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.

    Cellular Goods (CBX)
    Clear Leisure (CLP)
    Futura Medical (FUM)
    Mountfield Group (MOGP)
    Plutus Powergen (PPG)
    Savannah Resources (SAV)
    Transense Technologies (TRT)
    Tasty (TAST)
    Vertu Capital (VCBC)
    Westminster Group (WSG)

    Zakmir.com is a purely journalistic website – Zak Mir is a member of the National Union of Journalists. There is no intention here of providing financial advice. It is recommended you seek an independent professional opinion before deciding whether or not to take any action with regard to anything written here.

    (The opinions expressed here are those of the author, a columnist for Share Talk.)

    https://www.share-talk.com/share-talk-bulletin-board-heroes-thursday-4th-march-2021/
    9 min
  • Colin Bird, Executive Chairman, Galileo Resources (GLR.L) Interview
    Sale of Star Zinc project & Strategy Update

    Galileo Resources plc ("Galileo" or the "Company") announces that on 3 March 2021 it entered into a conditional agreement with Siege Mining Limited ("Siege") in relation to the ceding of ownership and operation of the Star Zinc Project (the "Star Zinc Project") for US$750,000 (being US$200,000 in relation to the large-scale exploration licence 19653-HQ-LEL (the "Star Zinc Project Licence") (the "Licence Consideration") and US$550,000 for Galileo ceding its participation in the Star Zinc Project and all exploration information which it has in relation to the Star Zinc Project (the "Project Assets") (the "Project Consideration"). Galileo will also be paid a royalty (proportion share) based on future sales of zinc from the Star Zinc Project for Galileo allowing Siege to use Galileo's information, know-how and commercial experience in relation to the Star Zinc Project (the "Agreement") .`
    Colin Bird Chairman & CEO said:

    " The Star Zinc project is a small but high-grade deposit situated in the expanding outskirts of Lusaka in Zambia in relative close proximity to housing, schooling and social amenities. The project lends itself to highly selective mining in a small area and as such is suitable for a small-scale community project involving artisanal mining operations and sorting of ore off-site. Galileo has interreacted with stakeholders to develop a solution for the mining and operation of the project which will benefit all stakeholders with Siege a local Zambian mining company taking on the operation of the project whilst having access to Galileo's information, know-how and commercial experience "

    https://www.share-talk.com/colin-bird-executive-chairman-galileo-resources-glr-l-interview/

    15 min